Your browser doesn't support javascript.
loading
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1.
Devasundaram, Santhi; Terpos, Evangelos; Rosati, Margherita; Ntanasis-Stathopoulos, Ioannis; Bear, Jenifer; Burns, Robert; Skourti, Stamatia; Malandrakis, Panagiotis; Trougakos, Ioannis P; Dimopoulos, Meletios-Athanasios; Pavlakis, George N; Felber, Barbara K.
Affiliation
  • Devasundaram S; Human Pathogenesis Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Rosati M; Human Pathogenesis Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Bear J; Human Pathogenesis Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Burns R; Human Pathogenesis Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Skourti S; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Malandrakis P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Trougakos IP; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Pavlakis GN; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Felber BK; Human Pathogenesis Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Am J Hematol ; 98(5): E123-E126, 2023 05.
Article in En | MEDLINE | ID: mdl-36810791
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Country of publication: